$PMVP 3 SEC Filings

Filed On	Filing
05 Oct 2026	Form 3: Eckler Matthew Joseph, Director No securities owned
23 Apr 2025	Form 3: Ticktin Robert, General Counsel & COO Holds 106,318 shares of Common Stock
11 Jan 2024	Form 3: Carulli Michael, Chief Financial Officer Holds 9,066 shares of Common Stock
08 Nov 2022	Form 3: Gallagher Carol Giltner, Director No securities owned
10 Jan 2022	Form 3: Flowers Kirsten, Director No securities owned
07 May 2021	Form 3: Euclidean Capital Llc, 10% owner and 8 others Holds 693,769 shares of Common Stock
07 Apr 2021	Form 3: Baum Charles M, Director No securities owned
24 Sep 2020	Form 3: Ra Capital MANAGEMENT, L.p., 10% owner and 2 others
24 Sep 2020	Form 3: Wellington Biomedical Innovation Master Investors (Cayman) I L.p., Former 10% Owner
24 Sep 2020	Form 3: Nextech V Oncology S.C.S., Sicav-sif, 10% owner
24 Sep 2020	Form 3: Interwest Partners X Lp, 10% owner and 4 others
24 Sep 2020	Form 3: Euclidean Capital Llc, 10% owner and 7 others
24 Sep 2020	Form 3: Double Epiphany, Llc, 10% owner Holds 1,282,026 shares of Common Stock
24 Sep 2020	Form 3: Levine Alison, 10% owner Holds 427,342 shares of Common Stock
24 Sep 2020	Form 3: Dawson Samantha, 10% owner Holds 427,342 shares of Common Stock
24 Sep 2020	Form 3: Boxer Capital, Llc, 10% owner and 4 others
24 Sep 2020	Form 3: Orbimed Advisors Llc, Director and 2 others
24 Sep 2020	Form 3: Stelzer Laurie, Director
24 Sep 2020	Form 3: Schroeder Thilo, Director
24 Sep 2020	Form 3: Thompson Peter A., Director

Comments